DANA-FARBER CANCER INSTITUTE
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1947-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.dana-farber.org/
LASER - a Phase 2 Trial of 177Lu-PSMA-617 as Systemic Therapy for Renal Cell Carcinoma
Phase 2
Not yet recruiting
- Conditions
- Renal Cell CarcinomaAdvanced Clear Cell Renal Cell CarcinomaKidney Cancer
- Interventions
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 24
- Registration Number
- NCT06964958
- Locations
- ๐บ๐ธ
Brigham and Women's Hospital, Boston, Massachusetts, United States
๐บ๐ธDana-Farber Cancer Institute, Boston, Massachusetts, United States
ACT Lung Health Intervention: Phase Two
Not Applicable
Not yet recruiting
- Conditions
- Smoking CessationSmoking BehaviorsSmoking, TobaccoSmoking, CigaretteSmoking (Tobacco) Addiction
- First Posted Date
- 2025-04-25
- Last Posted Date
- 2025-04-25
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 128
- Registration Number
- NCT06945120
- Locations
- ๐บ๐ธ
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
BOLSTER: Learning New Skills to Thrive
Not Applicable
Not yet recruiting
- Conditions
- Gastrointestinal CancerGynecologic CancerAdvanced Cancer
- First Posted Date
- 2025-04-20
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 600
- Registration Number
- NCT06936878
- Locations
- ๐บ๐ธ
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
๐บ๐ธThe University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial
Not Applicable
Not yet recruiting
- Conditions
- LymphomaLymphoma, HodgkinLymphoma, Non-HodgkinSedentary Behavior
- First Posted Date
- 2025-04-11
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 24
- Registration Number
- NCT06923397
- Locations
- ๐บ๐ธ
Dana Farber Cancer Institute, Boston, Massachusetts, United States
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
Not Applicable
Recruiting
- Conditions
- Acute LeukemiaLeukemia
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 75
- Registration Number
- NCT06907797
- Locations
- ๐บ๐ธ
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Deep Clinical Trajectory Modeling to Optimize Accrual to Cancer Clinical Trials
Not Applicable
Completed
- Conditions
- Cancer
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 20707
- Registration Number
- NCT06888089
- Locations
- ๐บ๐ธ
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
Not Applicable
Not yet recruiting
- Conditions
- NeuroblastomaHigh-risk Neuroblastoma
- First Posted Date
- 2025-02-18
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 84
- Registration Number
- NCT06831552
- Locations
- ๐บ๐ธ
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
Not Applicable
Not yet recruiting
- Conditions
- Chemotherapy Induced Peripheral Neuropathy (CIPN)Peripheral Neuropathy Due to ChemotherapyPeripheral Neuropathies
- First Posted Date
- 2025-02-04
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 21
- Registration Number
- NCT06807294
- Locations
- ๐บ๐ธ
Brigham and Women's Hospital, Boston, Massachusetts, United States
๐บ๐ธDana-Farber Cancer Institute, Boston, Massachusetts, United States
Pilot of a Trial Enrollment Diversity Dashboard
Not Applicable
Recruiting
- Conditions
- LeukemiaAcute Leukemia
- First Posted Date
- 2025-01-27
- Last Posted Date
- 2025-05-19
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 12
- Registration Number
- NCT06795139
- Locations
- ๐บ๐ธ
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Dance Study for Post-surgical Pain in Breast Cancer Survivors
Not Applicable
Not yet recruiting
- Conditions
- Breast CancerSurvivorshipPain, Postoperative
- First Posted Date
- 2025-01-03
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Dana-Farber Cancer Institute
- Target Recruit Count
- 30
- Registration Number
- NCT06758102
- Locations
- ๐บ๐ธ
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath